PT Darya-Varia Laboratoria Tbk (IDX: DVLA)
1,705.00
+15.00 (0.89%)
Sep 9, 2024, 3:45 PM WIB
DVLA Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 1,995,668 | 1,890,888 | 1,917,041 | 1,900,894 | 1,829,700 | 1,813,020 |
Revenue Growth (YoY) | 9.91% | -1.36% | 0.85% | 3.89% | 0.92% | 6.67% |
Cost of Revenue | 963,160 | 915,648 | 910,918 | 905,125 | 899,141 | 841,589 |
Gross Profit | 1,032,508 | 975,240 | 1,006,123 | 995,768 | 930,558 | 971,432 |
Selling, General & Admin | 820,850 | 797,516 | 830,427 | 806,071 | 726,548 | 678,004 |
Other Operating Expenses | 4,357 | -8,463 | -14,269 | -5,722 | -4,493 | -10,668 |
Operating Expenses | 825,207 | 789,053 | 816,158 | 800,349 | 722,055 | 667,336 |
Operating Income | 207,301 | 186,186 | 189,966 | 195,419 | 208,503 | 304,096 |
Interest Expense | -59.91 | -68.28 | -171.15 | -123.47 | -78.59 | - |
Interest & Investment Income | 2,432 | 2,071 | 3,621 | 4,144 | 4,290 | 5,783 |
Currency Exchange Gain (Loss) | 7,557 | - | 6,427 | 10,892 | 1,855 | -8,844 |
EBT Excluding Unusual Items | 217,200 | 188,189 | 199,843 | 210,332 | 214,570 | 301,035 |
Gain (Loss) on Sale of Assets | 4,269 | 3,450 | 1,230 | 1,179 | -500.45 | 215.13 |
Pretax Income | 221,469 | 191,638 | 201,073 | 211,511 | 214,069 | 301,250 |
Income Tax Expense | 52,087 | 45,302 | 51,698 | 65,006 | 51,996 | 79,467 |
Net Income | 169,381 | 146,336 | 149,375 | 146,505 | 162,073 | 221,783 |
Net Income to Common | 169,381 | 146,336 | 149,375 | 146,505 | 162,073 | 221,783 |
Net Income Growth | 121.84% | -2.03% | 1.96% | -9.61% | -26.92% | 10.53% |
Shares Outstanding (Basic) | 1,120 | 1,120 | 1,120 | 1,120 | 1,120 | 1,119 |
Shares Outstanding (Diluted) | 1,120 | 1,120 | 1,120 | 1,120 | 1,120 | 1,119 |
Shares Change (YoY) | - | - | - | - | 0.11% | 0.25% |
EPS (Basic) | 151.23 | 130.66 | 133.37 | 130.81 | 144.71 | 198.24 |
EPS (Diluted) | 151.23 | 130.66 | 133.37 | 130.81 | 144.71 | 198.24 |
EPS Growth | 121.84% | -2.03% | 1.96% | -9.61% | -27.00% | 10.25% |
Free Cash Flow | 87,789 | 11,270 | -74,245 | 350,220 | 43,777 | 213,583 |
Free Cash Flow Per Share | 78.38 | 10.06 | -66.29 | 312.70 | 39.09 | 190.91 |
Dividend Per Share | 65.000 | 108.000 | 119.000 | 114.000 | 110.000 | 107.000 |
Dividend Growth | -46.28% | -9.24% | 4.39% | 3.64% | 2.80% | 0% |
Gross Margin | 51.74% | 51.58% | 52.48% | 52.38% | 50.86% | 53.58% |
Operating Margin | 10.39% | 9.85% | 9.91% | 10.28% | 11.40% | 16.77% |
Profit Margin | 8.49% | 7.74% | 7.79% | 7.71% | 8.86% | 12.23% |
Free Cash Flow Margin | 4.40% | 0.60% | -3.87% | 18.42% | 2.39% | 11.78% |
EBITDA | 269,544 | 247,360 | 248,677 | 251,138 | 264,612 | 358,027 |
EBITDA Margin | 13.51% | 13.08% | 12.97% | 13.21% | 14.46% | 19.75% |
D&A For EBITDA | 62,243 | 61,174 | 58,712 | 55,719 | 56,109 | 53,931 |
EBIT | 207,301 | 186,186 | 189,966 | 195,419 | 208,503 | 304,096 |
EBIT Margin | 10.39% | 9.85% | 9.91% | 10.28% | 11.40% | 16.77% |
Effective Tax Rate | 23.52% | 23.64% | 25.71% | 30.73% | 24.29% | 26.38% |
Source: S&P Capital IQ. Standard template. Financial Sources.